These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35611893)

  • 1. [Topical issues of adequate control of dyslipidemia in the prevention of acute and recurrent cerebral circulatory disorders of ischemic type].
    Boitsov SA; Piradov MA; Tanashyan MM; Voznyuk IA; Yezhov MV; Oshchepkova EV; Sergienko IV; Shamalov NA; Skiba YB; Yanishevskiy SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(5):7-10. PubMed ID: 35611893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of dyslipidemia for stroke prevention from the perspective of J-STARS].
    Hosomi N; Matsumoto M
    Nihon Rinsho; 2016 Apr; 74(4):634-40. PubMed ID: 27333752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of statin therapy for stroke prevention.
    Sett AK; Robinson TG; Mistri AK
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1305-14. PubMed ID: 21985543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Dyslipidemia Treatment for Stroke Prevention.
    Aradine E; Hou Y; Cronin CA; Chaturvedi S
    Curr Neurol Neurosci Rep; 2020 Jun; 20(8):31. PubMed ID: 32572590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteins, stroke and statins.
    Pisciotta L; Bertolini S; Pende A
    Curr Vasc Pharmacol; 2015; 13(2):202-8. PubMed ID: 24188485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia as a risk factor for ischemic stroke.
    Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Top Med Chem; 2009; 9(14):1291-7. PubMed ID: 19849661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
    Rothwell PM; Algra A; Amarenco P
    Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke.
    Zhao L; Wang R; Song B; Tan S; Gao Y; Fang H; Lu J; Xu Y
    Int J Stroke; 2015 Jul; 10(5):752-8. PubMed ID: 25924059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatments in the secondary prevention of ischaemic stroke.
    Schulz UG
    Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia.
    Kopin L; Lowenstein C
    Ann Intern Med; 2017 Dec; 167(11):ITC81-ITC96. PubMed ID: 29204622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic dyslipidemia in patients with transient ischemic attack.
    Sirimarco G; Deplanque D; Lavallée PC; Labreuche J; Meseguer E; Cabrejo L; Guidoux C; Olivot JM; Abboud H; Lapergue B; Klein IF; Mazighi M; Touboul PJ; Bruckert E; Amarenco P
    Stroke; 2011 Aug; 42(8):2131-7. PubMed ID: 21737806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
    Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
    Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia and outcome in patients with acute ischemic stroke.
    Xu T; Zhang JT; Yang M; Zhang H; Liu WQ; Kong Y; Xu T; Zhang YH
    Biomed Environ Sci; 2014 Feb; 27(2):106-10. PubMed ID: 24625400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Internal medicine and neurological diseases: progress in diagnosis and treatment. Topics: III. Dyslipidemia and neurological disorders (cerebral infarction, dementia)].
    Hanyu H
    Nihon Naika Gakkai Zasshi; 2012 Aug; 101(8):2188-94. PubMed ID: 22973689
    [No Abstract]   [Full Text] [Related]  

  • 18. More than half of stroke patients were not given preventive drugs, study finds.
    Mayor S
    BMJ; 2016 Nov; 355():i6105. PubMed ID: 27852578
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient ischemic attack: Part II. Risk factor modification and treatment.
    Simmons BB; Gadegbeku AB; Cirignano B
    Am Fam Physician; 2012 Sep; 86(6):527-32. PubMed ID: 23062044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predilection role diabetes mellitus and dyslipidemia in the onset of ischemic stroke.
    Djelilovic-Vranic J; Alajbegovic A; Zelija-Asimi V; Niksic M; Tiric-Campara M; Salcic S; Celo A
    Med Arch; 2013; 67(2):120-3. PubMed ID: 24341059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.